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Embryoid body (EB) formation forms an important step in embryonic stem cell
differentiation in vivo. In murine embryonic stem cell (mESC) cultures EB formation
is inhibited by the inclusion of leukaemic inhibitory factor (LIF) in the medium.
Assembly of mESCs into aggregates by positive dielectrophoresis (DEP) in high
field regions between interdigitated oppositely castellated electrodes was found to
initiate EB formation. Embryoid body formation in aggregates formed with DEP
occurred at a more rapid rate—in fact faster compared to conventional methods—in
medium without LIF. However, EB formation also occurred in medium in which LIF
was present when the cells were aggregated with DEP. The optimum characteristic
size for the electrodes for EB formation with DEP was found to be 75–100 microns;
aggregates smaller than this tended to merge, whilst aggregates larger than this
tended to split to form multiple EBs. Experiments with ESCs in which green
fluorescent protein (GFP) production was targeted to the mesodermal gene brachyury
indicated that differentiation within embryoid bodies of this size may preferentially
occur along the mesoderm lineage. As hematopoietic lineages during normal
development derive from mesoderm, the finding points to a possible application of
DEP formed EBs in the production of blood-based products from ESCs. VC 2012
American Institute of Physics. [http://dx.doi.org/10.1063/1.3699969]
I. INTRODUCTION
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) hold great prom-
ise for cell therapy and regenerative medicine because they can self-renew and have a multili-
neage differentiation potential.1 Of particular interest is the induction of haematopoietic cells
from ESCs or induced iPSCs. Such haematopoietic cells could potentially be used for the large-
scale production of blood-based materials, including different types of blood cells.3,4
One of the steps in the induction of differentiated cells from ESCs or iPSCs is the forma-
tion of embryoid bodies (EBs). EBs are 3 dimensional aggregates in which tightly packed stem
cells undergo a program of differentiation which has many of the characteristics of early-stage
embryogenesis.2 A variety of methods have been developed to promote EB formation, and a
recent review of the methods used for the formation of EBs from ESCs has been given by
Bratt-Leal et al.5 The three most important methods for making EBs are culture-based, i.e., liq-
uid suspension culture in dishes,6 culture in methylcellulose semisolid media, and culture in
hanging drops.7,8 Other methods have included the use of micro well plates9–14 and aggregation
and encapsulation in microbeads.15 For the production of large numbers of EBs, stirred-
suspension cultures are performed using spinner flasks16 and stirred bioreactors.17,18
A major disadvantage of current culture-based methods is that they rely on natural aggrega-
tion and often provide poor control over EB size and the (initial) cell distribution. EB size can
affect fate decisions9,13,19 and influence the early differentiation of the different germ layers.22
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To obtain more direct control of EB size and uniformity several microscale technologies have
been developed.15,20–24 These have included the use of microfabricated adhesive stencils22 and
non-adhesive polyethylene glycol (PEG) hydrogel microwells of different diameters,15 as well
as microprinting techniques.16,25
An alternative microscale technology that can be used for the formation of cellular aggre-
gates is the use of physical micromanipulation techniques. Such techniques use a physical force
to guide cells, individually or in groups, to a predefined location, thus forming an aggregate.
Physical manipulation techniques give a high level of control over the initial distribution of the
cells and the number of cells. Physical micromanipulation techniques also allow different cell
types to be put within the initial aggregates in predetermined positions and numbers. This is
particularly important in attempts to induce the differentiation of ESCs or iPSC by coculture
with other cells, for example, during the induced differentiation of haematopoietic cells from
ESCs and iPSC.26,27 Physical micromanipulation techniques that have been used to date to
make cell aggregates from suspended cells have included optical tweezers,28–30 ultrasound,31,32
magnetic,33 electrical,34–39 and flow-based techniques.40–42 Of those, electrical techniques are
some of the most versatile.43,44 Advantages include the fact that electrical forces are universal
and can be used for living and non-living material. They can work at both long and short dis-
tance; be repulsive as well as attractive. Control of electric fields and their connection to com-
puter devices is straightforward, and electrodes can be used both for exerting electric fields as
well as measuring electrodes. Both DC and AC fields can be used, and when AC fields are
used, the frequency dependence of the polarizability of the particles can bring a measure of se-
lectivity. The application of DC or low-frequency electric fields can generate high electric field
strengths across the cell membrane, which can adversely affect cell viability.45 The electric field
strength generated across the cell membrane is significantly reduced at AC frequencies45,46
higher than 1MHz.
One of the AC electrokinetic techniques used for the manipulation of cells is dielectropho-
resis (DEP). DEP is the induced movement of particles in non-uniform electric fields.47–49 Both
positive DEP (particle movement towards areas of high field strength) and negative DEP (parti-
cle movement towards areas of low field strength) are possible, depending on the polarizability
of the particle relative to that of the surrounding medium.50 First described47 by Pohl in the
1950 s, the DEP method has since found a plethora of applications in particle manipulation,
characterization, and separation.47–49,51 Many of these are in the biomedical area. DEP forces
on cells are particularly strong as the membrane around cells and the interfacial polarization
processes across them induce particularly high dipole moments in the cells. Dispersions that
occur in the interfacial polarization processes make the DEP spectrum in the frequency range
10 kHz–100MHz highly frequency dependent, and most experiments are done in this frequency
range. Study of this frequency dependence can give important information about the properties
of the cells,47–49 including stem cells.52 The application of DEP in the characterization of stem
cells has recently been reviewed.53 One of the attractions of DEP is also that it is able to
manipulate and sort cells with the use of biochemical labels or other bioengineered tags and
without contact with surfaces.51
Although the electric fields used during the DEP process can affect cell viability,54 by
keeping the electric field across the cell membrane well below the strength above which
membrane breakdown occurs the viability of the cells during an experiment can be main-
tained,45,46 especially if the exposure time to the electric fields is short and if high frequen-
cies are used.45
One of the applications of DEP is patterning of cells and the formation of cell constructs.
This has included the construction of three dimensional cell aggregates.34–39,55,56 Potential
applications of such cell arrays and aggregates created with DEP have included biofilms for
biocatalysis and bioremediation,57 cell-based biosensors,46 models for developmental or disease
studies,58 and engineered tissues for regenerative medicine.34–39 Applications of DEP in tissue
engineering have recently been reviewed.43,44 In this study we describe the application of posi-
tive DEP in the construction of embryoid bodies. The study forms part of a research pro-
gramme aimed at the development of artificial stem cell microenvironments.56
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II. MATERIALS AND METHODS
A. Cells
ESC lines used were murine ESC line 7a, in which green fluorescent protein (GFP) expres-
sion is controlled by a constitutive promoter,59 and Brachyury ESC line Bry-ESC,60 in which
GFP expression was under the control of the mesoderm-specific Bry promoter. Both cell lines
were grown as described previously.61,62 Briefly, 106 ESCs were plated onto T25 culture flasks
coated with 0.1% gelatin in 10ml GMEM medium supplemented with 10% fetal calf serum
(FCS), 1% MEM non essential amino acids (Invitrogen), 1 lgml1 b-mercaptoethanol and
10 lgml1 sodium pyruvate, with 100U/ml added leukaemia inhibitory factor (LIF). LIF inhib-
its differentiation, and the presence of LIF, therefore, kept the ESCs in an undifferentiated state.
Passaging was performed every 48 h when the cells reached a confluency of 80%. For dielectro-
phoretic experiments the cells were washed with 300mM D-sorbitol in deionised water twice to
reduce the medium conductivity and finally resuspended in 300mM D-sorbitol solution
(r¼ 4.7 104 S m1) for patterning with positive DEP.
B. Dielectrophoresis
A dielectrophoresis setup was used as described previously.38,39,55,56 The system was based
around glass slides with ITO microelectrodes of the interdigitated, oppositely castellated design
with characteristic sizes between 25 and 250 lm, made using photolithography. Although avail-
able, electrodes with a characteristic size of 25 lm were not used in the experiments. In some
experiments, to minimize cell adhesion to the surface, the glass slides with ITO microelectrodes
were incubated for 48 h in 1-hexadecanethiol (Sigma-Aldrich). The slides were washed thor-
oughly with deionized water and wiped carefully with water soaked tissue paper. The slides
were checked for defects and the presence of any particles prior to use.
A chamber was constructed on top of each slide from two strips of insulating tape and a
microscopic slide coverslip. The chamber covered a single microelectrode region at a time. The
height of the chamber was 560 lm, its length 20mm, and its width 5mm. Following steriliza-
tion by autoclaving the chamber was filled with the low conductivity 300mM D-sorbitol solu-
tion with a pipette. Electric fields were then generated between the microelectrodes by applying
a signal with a frequency of 1MHz with a Thurlby-Thandar TG120 function generator to
selected microelectrodes. Cells were introduced with a pipette into the chamber and attracted to
the high field regions between the electrodes. Fresh sorbitol solution was passed through the
chamber by adding sorbitol solution on one side of the chamber and removing it from the other.
This made it possible to redistribute the cells over the electrodes, remove non-attracted cells,
and maintain a low conductivity in the chamber. 1MHz was chosen because at this frequency,
in the very low conductivity sorbitol medium, the cells would experience a strong positive DEP
force. As shown previously,38 a voltage of 10Vpk-pk gave an electric field strength that was
strong enough to hold the cells between electrodes with a characteristic size of 25–100 lm,
without strongly affecting cell viability. For electrodes with a characteristic size between 125
and 250 lm larger electric field strengths were needed to hold cells against any hydrodynamic
forces created during the assembly process. A voltage of 20Vpk-pk was experimentally found to
be satisfactory.
To immobilize the cells in the aggregates, as a first step the electric field was maintained
for a further 10–15min. This caused the cells to stick to each other by non-specific adhesive
forces.38 Following this, the sorbitol solution in the chamber was replaced with a 25% BD Pur-
amatrixTM solution (3 DM Inc, Cambridge, USA).63 Puramatrix is a fully synthetic peptide and
contains no detectable growth factors or cytokines. The Puramatrix solution (made by mixing
the Puramatrix precursor solution supplied by the distributor with 300mM sorbitol solution)
was introduced into the chamber by carefully adding the Puramatrix solution at one end of the
chamber using a pipette and removing sorbitol solution from the other end with another pipette.
Once the chamber had been filled with Puramatrix solution the electric field was switched off
and GMEM growth medium was added at the edge of the chamber to initiate gel formation.
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Gel formation took approximately 10min from the introduction of growth medium. The cham-
ber was then placed in an incubator at 37 C, 5% CO2, and images were taken of the aggregates
over a period of 24–72 h.
III. RESULTS AND DISCUSSION
A. Aggregate formation of 7a murine ESCs with DEP
Aggregates were made of 7a GFP-expressing ESCs at microelectrodes of different sizes
ranging from 50 to 250 lm and immobilized in 25% Puramatrix. Following this, the cells were
incubated in GMEM growth medium without LIF to initiate differentiation. Previous experi-
ments within our group on stem cell microniches had used single ESCs,56 and EB formation
had not been attempted. Patterning of ESCs with DEP has also been reported by other groups,
but only monolayers had been formed.64 All human and murine ES cells are known to need
aggregation to initiate EB formation.7,65 The aggregates formed here were all 3-dimensional
and many cell layers high.39
Figures 1–3 show brightfield images of aggregates of ESCs immediately after they had
been formed, and green fluorescent images of the aggregates after 24 h. 7a ESCs produce GFP
constitutively, and GFP production was therefore used only to make tracking of cells easier. In
7a ESCs GFP production is not a measure of differentiation. At all electrodes sizes used the
ESCs condensed into embryoid bodies.
Figure 1 shows ESC aggregates formed at microelectrodes with a characteristic size of
50 lm. Cells were introduced into the chamber from right to left. This caused more cells to
accumulate in each aggregate on the right hand side and less on the left. Figure 1(b) shows that
after 24 h of incubation the cells had started to form EB-like structures. On the right hand side,
where large aggregates had formed which were very close to each other, the aggregates had
started to merge.
Figure 2 shows cell behavior typical of that of microelectrodes with characteristic sizes of
75 lm. At this electrode size the initial distance between the aggregates of ESCs was slightly
larger than between aggregates formed at electrodes with a characteristic size of 50 lm. When
the cells initiated EB formation most aggregates formed single EBs, though some secondary
EB formation can also be seen. Cell behavior at electrodes with a characteristic size of 100lm
was similar to that at 75 lm electrodes.
At regions above 100 lm the cells within an individual aggregate condensed into several
high density regions, causing the aggregates to split. Figure 3 shows aggregates formed at
microelectrodes with a characteristic size of 200 lm.
FIG. 1. Aggregates of 7a ESCs formed by DEP at 10Vpk-pk, 1MHz in the 50lm microelectrode regions. The aggregates
were immobilised in 25% Puramatrix and provided with medium without LIF. (a) Bright field image of aggregates at 0 h.
Cells were introduced from right to left, and more cells can be seen to have accumulated in the aggregates at the right hand
side than on the left hand side. (b) Green fluorescent image of aggregates after 24 h of incubation. Aggregates can be seen
to have merged, especially in regions where there were more cells at the start.
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FIG. 2. Aggregates of 7a ESCs formed by DEP at 10Vpk-pk, 1MHz in the 75lm microelectrode regions. The aggregates
were immobilised in 25% Puramatrix and provided with GMEM growth medium without LIF. (a) Bright field image of
aggregates fromed with DEP at time zero. (b) Green fluorescent image of aggregates after 24 h of incubation. After 24 h
most individual aggregates have started to form a single EB.
FIG. 3. Aggregates of 7a ESCs formed by DEP at 20Vpk-pk, 1MHz in the 200lm microelectrode regions. The aggregates
were immobilised in 25% Puramatrix and provided with GMEM growth medium without LIF. (a) Aggregates at 0 h. (b)
Aggregates after 24 h of incubation. Within the aggregates many small cell clumps/EBs can be seen to have formed.
FIG. 4. When not aggregated with DEP, and resuspended in medium with LIF, ESCs resumed undifferentiated growth as a
monolayer.
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Although no attempt was made to directly measure cell viability, the continued production
of GFP and condensation of the ESCs into EBs indicated that the ESCs survived the DEP as-
sembly procedure well. EB formation was also fast. EB formation started within 24 h under the
conditions used in our experiments. In established protocols for the induction of EBs in suspen-
sion culture technique takes 3–5 days incubation of cells suspended in differentiation medium,
whereas the hanging drop method usually requires a 2 day incubation period.66 Accelerated EB
formation in engineered aggregated of ESCs has been reported previously,67 a finding which
has been confirmed in our experiments.
The optimum initial aggregate size for embryonic body formation appeared to be around
75–100 micron. Too small an aggregate size led to dispersion and merging of adjacent
FIG. 5. Aggregate development in 25% Puramatrix in presence of LIF. Aggregates were formed with 7a ESCs at interdigitated
oppositely castellated microelectrodes with a characteristic size of 50lm using a 10Vpk-pk, 10MHz signal. (a) Aggregates at 0 h,
immediate after their formation; (b) Aggregates after 24 h. Significant condensation of the cells in the aggregates has occurred;
(c) Aggregates after 48 h, showing the aggregates have condensed further. At electrode sizes larger than 50lm similar behavior
was shown, i.e., delayed EB formation in medium LIF compared to medium without LIF.
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aggregates; too large an aggregate size causes the aggregate to break up into many EBs. The
optimum size is similar to that observed in other experiments on EB formation.13
B. Effect of LIF on EB formation
In the previous experiments EB formation was induced by the aggregation of the ESCs
with DEP and omission of LIF in the growth medium. To determine whether it was the aggre-
gation of the cells with DEP that induced EB formation or the omission of LIF, a number of
control experiments were performed. In the first set of control experiments cells were exposed
to the same procedure as the cells which were aggregated with DEP, but electric field exposure
was omitted, and no aggregation therefore occurred. When subsequently grown in medium with
LIF the cells resumed undifferentiated growth as a monolayer, indicating that the handling of
FIG. 6. Aggregates of 7a murine ESCs formed by DEP at 10Vpk-pk, 1MHz in the 75lm microelectrode regions, treated
with 1-hexadecanethiol. The aggregates were immobilised in 25% Puramatrix and provided with GMEM growth medium
without LIF. (a) 0 h (b) 24 h, (c) 48 h.
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the cells itself, including their temporary suspension in a low conductivity sorbitol solution, did
not change the characteristics of the stem cells (see Fig. 4).
In the second set of control experiments the cells were aggregated with DEP and subse-
quently grown in a medium which contained LIF at the same concentration as normal growth
medium (100U/ml). Under these conditions the cells in the aggregates delayed EB formation
and formed irregular EBs (Fig. 5). However, EB formation still occurred, typically within 48 h.
These results indicate that the aggregation with DEP is the primary factor that induces EB
formation.
It is not known whether the high electric fields used themselves played any role in ESC
differentiation. Very low frequency (1Hz) AC sinusoidal electric fields have been shown to
affect stem cell differentiation,66 but the AC fields used in this study were of a much higher
frequency (1MHz). Further experiments would be needed to determine this.
C. Influence of properties of the electrode surface on the merging of aggregates
Short term experiments (within a 24 h timeframe) indicated that significant exchange of
cells occurred between adjacent aggregates when the aggregates were near. Longer term experi-
ments showed63 that migration could also occur over longer distances. Such cell movements are
likely to affect EB formation and therefore affect the differentiation of the ESCs that form the
EB.
To investigate the role of the electrode surface in the movement of cells between aggre-
gates process, DEP slides were treated with 1-hexadecanethiol. Treatment with 1-
hexadecanethiol would make the surface highly hydrophobic and could be expected to prevent
cells from adhering to the surface and travelling between aggregates. Figure 6 shows the effect
of treating the surface with 1-hexadecanethiol on EB formation. Unlike the experiments in
which the surface was left untreated, there was little or no evidence of exchange of cells
between EBs, and merging of aggregates did not occur.
FIG. 7. Aggregate of Bry-GFP ESCs at 75lm electrode region at zero hours, formed by applying a 1MHz, 10Vpk-pk signal
to interdigitated oppositely castellated electrodes. The aggregate was immobilized in 25% Puramatrix and incubated with
GMEM growth medium without LIF. (a) Green fluorescence image of an aggregate at zero hours showing the region of in-
terest for image analysis. (b) Bright field image of an aggregate at zero hours. (c) Green fluorescent image of an aggregate
at 24 h showing the region of interest. (d) Bright field image of an aggregate forming an EB after 24 h.
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D. Differentiation occurs along the mesoderm lineage
Aggregates were made with Bry ESCs in order to investigate whether aggregation by DEP
triggers differentiation along the mesoderm lineage. Bry ESCs will only express GFP when the
mesoderm programme is initiated. Aggregate size is known to affect the type of cells the ESCs
differentiate into.9,13,19,22 Differently sized microelectrodes were therefore used in order to
obtain aggregates with different sizes. However, because aggregates formed at electrodes with a
characteristic size larger than 125 lm tended to split up into smaller units, no electrodes with a
characteristic size larger than 100 lm were used. Green fluorescent and brightfield images were
taken of the aggregates with a Leica TCS2 confocal microscope, and the average green inten-
sity in the aggregates was determined using image analysis.
At all electrode sizes (50, 75, and 100 lm) the aggregates formed by DEP condensed into
EBs. An example of an aggregate formed with Bry ESCs with DEP and the resultant EB is
shown in Fig. 7.
The average intensity values of the green fluorescence in the aggregates in the three elec-
trode regions at 0 and 24 h are shown in Fig. 8. The EBs formed in the 50 lm region showed a
negligible increase in green fluorescence whereas the EBs formed in the 75 and 100lm regions
showed significant increases in the intensity values. This indicates that the cells in the 75 and
100 lm regions are differentiating along the mesoderm lineage, but the cells in the 50 lm
region are not. This is most likely due to the smaller size of aggregate in the 50 lm region at
the start of the experiment.
IV. CONCLUSIONS
We have shown that the attraction of ESCs by positive DEP to high field regions between
the castellations of interdigitated oppositely castellated electrodes can induce the formation of
EBs. The optimum size for the formation of EBs was 75–100 micron. EB formation in medium
without LIF occurred with 24 h. This is significantly faster than EB formation in conventional
culture-based methods, which typically takes 2–3 days. Condensation into EB-like aggregates
also occurred in the presence of the LIF. This appears to indicate that EB formation is induced
simply by the assembly of the ESCs into an aggregate. Experiments with Bry ESCs indicated
that the differentiation of the stem cells occurs along the mesoderm lineage. Differentiation
along the mesoderm lineage is a first step towards the differentiation towards the haemato-
poietic lineage. The haematopoietic lineage leads to all types of blood cells. The results there-
fore not only confirm the utility of DEP in the study of stem cells53,68,69 but also indicate a
FIG. 8. Comparative study of the average intensity values in Bry ESC aggregates. Data were plotted at 0 and 24 h for Bry
ESC aggregates formed at different microelectrode regions. Also shown are 95% confidence values in the form of error
bars.
024101-9 Agarwal et al. Biomicrofluidics 6, 024101 (2012)
possible role for DEP in the construction of EBs from ESCs for as a first step in the formation
of blood-based products.3,4
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